Medical specialists from Canada tagged as investigators in clinical trials studying Homozygous Familial Hypercholesterolemia
Total 4 results
-
Daniel Gaudet, MDSeen in:
- Quebec, Chicoutimi, Ecogene-21
Trials:- NCT02135705 (Principal Investigator)
- NCT05089084 (Principal Investigator)
-
Jacques Genest, MDSeen in:
- Quebec, Montreal, Research Institute of the McGill University Health Centre: Glen site
- Quebec, Montréal, McGill University
Trials:- NCT02135705 (Principal Investigator)
- NCT02009345 (Principal Investigator)
-
Robert Hegele, MDSeen in:
- Ontario, London, Robarts Research Institute
Trials:- NCT02135705 (Principal Investigator)
- NCT05089084 (Principal Investigator)
-
Thomas Ransom, MDSeen in:
- Nova Scotia, Halifax, Nova Scotia Health Authority
Trials:- NCT02135705 (Principal Investigator)
Conditions:
Clinical Trials on Homozygous Familial Hypercholesterolemia
-
Novartis PharmaceuticalsActive, not recruitingFamilial Hypercholesterolemia - HomozygousGreece, Lebanon, Turkey, France, Canada, Malaysia, Netherlands, United States
-
REGENXBIO Inc.National Heart, Lung, and Blood Institute (NHLBI)TerminatedHomozygous Familial Hypercholesterolemia (HoFH)United States, Canada, Italy, Netherlands
-
Novartis PharmaceuticalsRecruitingHeterozygous or Homozygous Familial HypercholesterolemiaNetherlands, Israel, Hungary, Italy, Germany, Turkey, Spain, United States, France, Norway, Russian Federation, South Africa, United Kingdom, Canada, Switzerland, Brazil, Lebanon, Slovenia, Poland, Taiwan, Malaysia
-
AmgenCompletedHomozygous Familial Hypercholesterolemia HoFHIndia
-
Organon and CoCompletedPrimary Hypercholesterolemia | Homozygous Familial Hypercholesterolemia
-
Institut Investigacio Sanitaria Pere VirgiliRecruitingFamilial Hypercholesterolemia | Familial Hypercholesterolemia - Homozygous | Familial Hypercholesterolemia - HeterozygousSpain
-
AmgenCompletedFamilial HypercholesterolemiaCanada, Italy, Norway, Belgium, United States, Turkey, Australia, Austria, South Africa, Poland, Switzerland, Spain, Portugal, Slovenia, Brazil, Russian Federation, Hungary, United Kingdom, Colombia, Czechia, Netherlands, Greece, Ma...
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, South Africa, Australia, Austria, Canada, Czechia, France, Greece, Italy, Japan, Ukraine
-
Daniel GaudetUltragenyx Pharmaceutical IncActive, not recruitingSafety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial HypercholesterolemiaHomozygous Familial HypercholesterolemiaCanada
-
Nantes University HospitalCompletedStudy of cardiovAscular Contrasted Phenotypes in Patients With FamIliaI hypercholesteRolemia (SAFIR)Homozygous Familial HypercholesterolemiaFrance